Zhejiang Shouxiangu Pharm Co (603896) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.94 Million ≈ $3.06 Million USD) by net assets (CN¥2.31 Billion ≈ $338.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603896 equity to assets ratio to measure how much of total assets are equity-financed.

Zhejiang Shouxiangu Pharm Co - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Shouxiangu Pharm Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Shouxiangu Pharm Co cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Shouxiangu Pharm Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Samhi Hotels Limited NSE:SAMHI	0.090x
Jtekt India Limited NSE:JTEKTINDIA	0.020x
D I Corp KO:003160	-0.002x
Nel ASA OL:NEL	-0.023x
Beijing Forever Technology Co Ltd SHE:300365	0.001x
Shanxi Antai Group Co Ltd SHG:600408	0.053x
Hangzhou Zhongya Machinery Co Ltd SHE:300512	0.026x
SUNIC SYSTEM Co. Ltd KQ:171090	-0.171x

Annual Cash Flow Conversion Efficiency for Zhejiang Shouxiangu Pharm Co (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shouxiangu Pharm Co from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 603896 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.26 Billion ≈ $330.77 Million	CN¥228.07 Million ≈ $33.37 Million	0.101x	+8.44%
2024-12-31	CN¥2.29 Billion ≈ $335.69 Million	CN¥213.44 Million ≈ $31.23 Million	0.093x	-35.88%
2023-12-31	CN¥2.17 Billion ≈ $317.73 Million	CN¥315.06 Million ≈ $46.10 Million	0.145x	-18.98%
2022-12-31	CN¥1.91 Billion ≈ $278.84 Million	CN¥341.28 Million ≈ $49.94 Million	0.179x	-2.21%
2021-12-31	CN¥1.62 Billion ≈ $237.06 Million	CN¥296.70 Million ≈ $43.42 Million	0.183x	-5.25%
2020-12-31	CN¥1.33 Billion ≈ $194.08 Million	CN¥256.36 Million ≈ $37.51 Million	0.193x	+9.00%
2019-12-31	CN¥1.17 Billion ≈ $171.57 Million	CN¥207.92 Million ≈ $30.42 Million	0.177x	+1.82%
2018-12-31	CN¥984.74 Million ≈ $144.10 Million	CN¥171.51 Million ≈ $25.10 Million	0.174x	+36.71%
2017-12-31	CN¥869.75 Million ≈ $127.27 Million	CN¥110.80 Million ≈ $16.21 Million	0.127x	-41.72%
2016-12-31	CN¥436.93 Million ≈ $63.94 Million	CN¥95.52 Million ≈ $13.98 Million	0.219x	-5.25%
2015-12-31	CN¥368.53 Million ≈ $53.93 Million	CN¥85.03 Million ≈ $12.44 Million	0.231x	-28.12%
2014-12-31	CN¥320.56 Million ≈ $46.91 Million	CN¥102.90 Million ≈ $15.06 Million	0.321x	+45.99%
2013-12-31	CN¥299.50 Million ≈ $43.83 Million	CN¥65.85 Million ≈ $9.64 Million	0.220x	-32.93%
2012-12-31	CN¥138.37 Million ≈ $20.25 Million	CN¥45.36 Million ≈ $6.64 Million	0.328x	--

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology

Market Cap

$423.25 Million

CN¥2.89 Billion CNY

Market Cap Rank

#13102 Global

#3866 in China

Share Price

CN¥14.59

Change (1 day)

-0.41%

52-Week Range

CN¥12.95 - CN¥22.65

All Time High

CN¥56.07